doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

    Federal Negotiations For Medicare Prescription Drug Prices Would Stifle Industry Innovation, Report Finds
"The Human Cost of Federal Price Negotiations: The Medicare Prescription Drug Benefit and Pharmaceutical Innovation," Manhattan Institute for Policy Research: The report by Manhattan Institute senior fellow Benjamin Zycher analyzes the likely effect of federal government price negotiations for medications under the Medicare prescription drug benefit. According to the report, mandating federal price negotiations would substantially reduce the number of new drugs brought to the market each year (Zycher, "The Cost of Federal Price Negotiations: The Medicare Prescription Drug Benefit and Pharmaceutical Innovation," 11/28).

"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Publication Date: 2006-12-01 14:00

© 2006-2007 pharmacy-and-drugs.com. All rights reserved.